This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Six in ten people told Kantar that privacy concerns like data breaches prevent them from using wearable tracking devices or using telemedicine services. While most consumers say technology enables us to be connected with our health care, trust is a barrier to digital engagement.
This new work-flow for clinicians led to fast-adoption of virtual care platforms – telemedicine, tele-conferencing with patients via apps like Zoom and Skype along with commercially-built telehealth channels, and the prescription and use of remote health monitoring devices placed in patients’ homes.
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.
Evolution and Benefits of DHTs in Neurology Trials DHTs – like wearables, mobile health apps, and telemedicine platforms – have for example significantly impacted the design and execution of neurology trials. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%
Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. Healthcare IT Today had the opportunity to catch up with several interesting company leaders including Dolma Tsundu from Flutter Care , Eunice Wu from Asepha , and Marc Paderon from Pontosense.
Debut Biotech : A leading cell-free biomanufacturing company that launched its own skin care product line in 2023 and raised a $20 million Series B led by L’Oreal. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.
Digital Health Solutions: Digital health solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making. SolasCure: This UK-based biotech company raised £15 million to develop a wound cleaning product based on an enzyme cloned from medical maggots.
While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Unlike broader telemedicine plays like Teladoc, Doximitys physician-centric model and subscription-based revenue95% from pharma and health systemsgive it a unique edge.
Telemedicine, remote monitoring, and other digital tools became crucial for patients and healthcare providers. However, as with any early-stage biotech company, there's inherent risk involved, and their long-term success hinges on the successful development and commercialization of their drugs.
For a skydiver who’s motto is “Just jump out and go”, the journey from chasing down Sandanista kidnappers to driving Disney strategy to genomics pioneer sounds sort of rational. Lisa Alderson, founder and CEO of Genome Medical, is one of those special someones who thrives on adrenaline and channels it to great effect. Lisa went […].
After receiving more than 38,000 public comments, the Drug Enforcement Administration is extending the telemedicine flexibilities for prescribing controlled medications beyond the end of the public health emergency on May 11. The silver lining: Healthcare is the leading sector, though most funds are going to biotech.
News and Studies The American Telemedicine Association released three tools aimed at addressing disparity and inequity in care : Digital Infrastructure Disparities Score and Map, Economic and Social Value-Added Calculator, and a toolkit including all previously released resources.
Our mission is to transform global health by bringing quality virtual care to the underserved – which is why our telemedicine solutions treat patients in over 55 countries. Recently a GlobalMed contractor transformed a village in Kumasi, Ghana with just one telemedicine station. Over 300 patients showed up, most on foot.
The water is muddy, according to the report, because few vendors distinguish between telemedicine – a replacement for an in-person appointment – and virtual care – a broader set of services. The Biotech Breakthrough Awards Program announced its 2022 award winners.
One leading sector of the digital health space, telemedicine companies, generated three times the amount of financing they received in Q1 2019, raising $788 million in venture capital backing, compared to $220 million in the first quarter of 2019. " Health start-ups look singularly poised to weather the coronavirus storm.
Telemedicine, remote monitoring, and other digital tools became crucial for patients and healthcare providers. However, as with any early-stage biotech company, there's inherent risk involved, and their long-term success hinges on the successful development and commercialization of their drugs.
With advances in telemedicine, meanwhile, and with rapid increases in the numbers of next-generation medical devices capable of harnessing artificial intelligence, both doctors and patients now have even more medical information available to them.
A telemedicine platform that allows patients to consult with doctors remotely. Enlighten is a biotech company that is developing gene-editing therapies for cancer and other diseases. A digital health record system that allows patients to access their medical records online.
We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.
Remote Healthcare and Telemedicine: Consolidation of Telehealth Providers: Mergers and acquisitions among telemedicine companies to create larger, more comprehensive platforms. Strategic Partnerships: Collaborations between established players and AI companies to develop advanced analytics and predictive modelling tools.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content